Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 1, 2019 Off

Semma Therapeutics Announces Pre-Clinical Proof-of-Concept in Two Lead Programs in Type 1 Diabetes

By BusinessWire

– Stem cell-derived islets successfully reduce insulin requirements in diabetic non-human primates – – Novel device successfully protects stem cell-derived…

July 1, 2019 Off

Puma Biotechnology Submits a Supplemental New Drug Application to U.S. FDA for Neratinib to Treat HER2-Positive Metastatic Breast Cancer

By BusinessWire

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, has submitted a supplemental New Drug Application (sNDA) to the…

July 1, 2019 Off

Ocular Therapeutix™ Announces Commercial Launch of DEXTENZA® (dexamethasone intracanalicular insert) 0.4 mg for Ophthalmic Use in the United States

By BusinessWire

Pass-through payment status and C-code from the Centers for Medicare and Medicaid Services (CMS) now active BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular…

July 1, 2019 Off

Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline With New First-in-Class Compound from Yuhan Corporation

By BusinessWire

Boehringer Ingelheim focuses on the development of next generation NASH treatments that target all three key drivers of the disease…

July 1, 2019 Off

 KalVista Pharmaceuticals Announces Changes to Board of Directors

By BusinessWire

 – Martin Edwards, MD, Elected as Chair – – Chair Richard H. Aldrich Resigns in Planned Transition – CAMBRIDGE, Mass.…

July 1, 2019 Off

Bicycle Therapeutics Announces Positive Topline Results from Oxurion’s Phase I Trial Using a Novel Bicycle-based Plasma Kallikrein Inhibitor for the Treatment of Diabetic Macular Edema

By BusinessWire

Phase I results provide additional clinical activity data for Bicycles CAMBRIDGE, U.K., & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering…

July 1, 2019 Off

Top 5 Vendors in the Global Neuroendocrine Tumors Therapeutics Market 2019-2023 | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–#Research–The global neuroendocrine tumors therapeutics market is highly concentrated. Because of the high investment required for drug development and…

July 1, 2019 Off

Viela Bio Appoints Mitchell Chan as Chief Financial Officer

By BusinessWire

GAITHERSBURG, Md.–(BUSINESS WIRE)–Viela Bio today announced the appointment of Mitchell Chan as Chief Financial Officer, effective July 1. In this…

July 1, 2019 Off

Century Therapeutics Launches With USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform

By BusinessWire

Created by Versant Ventures and partnered with Fujifilm to develop iPSC-derived adaptive and innate immune effector cell therapies Leaps by…

July 1, 2019 Off

Platelet BioGenesis Appoints Biotech Industry Veteran Sam Rasty, Ph.D., as President and Chief Executive Officer

By BusinessWire

New leader to rapidly build team and capabilities to scale unique stem cell-derived platelet manufacturing platform, advance core program to…

Posts pagination

Previous 1 … 3,035 3,036 3,037 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine